{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T02:48:26Z","timestamp":1768272506460,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,9,4]],"date-time":"2008-09-04T00:00:00Z","timestamp":1220486400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s00428-008-0653-2","type":"journal-article","created":{"date-parts":[[2008,9,3]],"date-time":"2008-09-03T08:47:51Z","timestamp":1220431671000},"page":"329-338","source":"Crossref","is-referenced-by-count":38,"title":["Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy"],"prefix":"10.1007","volume":"453","author":[{"given":"Carmen","family":"Valbuena","sequence":"first","affiliation":[]},{"given":"El\u00edsio","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Manuela","family":"Bustorff","sequence":"additional","affiliation":[]},{"given":"Mariana","family":"Ganh\u00e3o","sequence":"additional","affiliation":[]},{"given":"Sandra","family":"Relvas","sequence":"additional","affiliation":[]},{"given":"Rosete","family":"Nogueira","sequence":"additional","affiliation":[]},{"given":"F\u00e1tima","family":"Carneiro","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Paulo","family":"Oliveira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2008,9,4]]},"reference":[{"key":"653_CR1","first-page":"3733","volume-title":"The metabolic and molecular bases of inherited disease","author":"RJ Desnick","year":"2001","unstructured":"Desnick RJ, Ioannou YA, Eng CM (2001) \u03b1-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS et al (eds) The metabolic and molecular bases of inherited disease. 8th edn. McGraw Hill, New York, pp 3733\u20133774","edition":"8"},{"key":"653_CR2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000060184","volume-title":"Rare kidney diseases (contributions to nephrology, vol 136)","author":"RJ Desnick","year":"2001","unstructured":"Desnick RJ, Wasserstein MP, Banikazemi M (2001) Fabry disease (\u03b1-Galactosidase A deficiency): renal involvement and enzyme replacement therapy. In: Schieppati A, Daina E, Sessa A, Remuzzi G (eds) Rare kidney diseases (contributions to nephrology, vol 136). Karger, Basel, pp 174\u2013192"},{"key":"653_CR3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","volume":"138","author":"RJ Desnick","year":"2003","unstructured":"Desnick RJ, Brady R, Barranger J et al (2003) Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338\u2013346","journal-title":"Ann Intern Med"},{"key":"653_CR4","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/ndt\/gfm848","volume":"23","author":"A Ortiz","year":"2008","unstructured":"Ortiz A, Oliveira JP, Waldek S et al (2008) Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy. Nephrol Dial Transplant 23:1600\u20131607","journal-title":"Nephrol Dial Transplant"},{"key":"653_CR5","first-page":"135","volume":"14","author":"MF Lyon","year":"1962","unstructured":"Lyon MF (1962) Sex chromatin and gene action in the mammalian X chromosome. Am J Hum Genet 14:135\u2013418","journal-title":"Am J Hum Genet"},{"key":"653_CR6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/jmg.2005.036327","volume":"43","author":"PB Deegan","year":"2006","unstructured":"Deegan PB, Baehner AF, Barba Romero M-\u00c1 et al (2006) Natural history of Fabry disease in females in the Fabry outcome survey. J Med Genet 43:347\u2013352","journal-title":"J Med Genet"},{"key":"653_CR7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","volume":"93","author":"WR Wilcox","year":"2008","unstructured":"Wilcox WR, Oliveira JP, Hopkin RJ et al (2008) Females with Fabry disease frequently have major organ involvement: lessons from the Fabry registry. Mol Genet Metab 93:112\u2013128","journal-title":"Mol Genet Metab"},{"key":"653_CR8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH (2001) Anderson\u2013Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females [Letter]. J Med Genet 38:769\u2013775","journal-title":"J Med Genet"},{"key":"653_CR9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1523-1755.2002.00097.x","volume":"61","author":"R Thadhani","year":"2002","unstructured":"Thadhani R, Wolf M, West ML et al (2002) Patients with Fabry disease on dialysis in the United States. Kidney Int 61:249\u2013255","journal-title":"Kidney Int"},{"key":"653_CR10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ki.1978.32","volume":"13","author":"M-C Gubler","year":"1978","unstructured":"Gubler M-C, Lenoir G, Gr\u00fcnfeld J-P et al (1978) Early renal changes in hemizygous and heterozygous patients with Fabry\u2019s disease. Kidney Int 13:223\u2013235","journal-title":"Kidney Int"},{"key":"653_CR11","first-page":"109","volume":"15","author":"A Sessa","year":"2002","unstructured":"Sessa A, Tosoni A, Nebuloni M et al (2002) Renal ultrastructural findings in Anderson\u2013Fabry disease. J Nephrol 15:109\u2013112","journal-title":"J Nephrol"},{"key":"653_CR12","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1097\/01.ASN.0000016684.07368.75","volume":"13","author":"J Alroy","year":"2002","unstructured":"Alroy J, Sabnis S, Kopp JB (2002) Renal pathology in Fabry disease. J Am Soc Nephrol 13:S134\u2013S138","journal-title":"J Am Soc Nephrol"},{"key":"653_CR13","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/modpathol.3800634","volume":"19","author":"EG Fischer","year":"2006","unstructured":"Fischer EG, Moore MJ, Lager DJ (2006) Fabry disease: a morphologic study of 11 cases. Mod Path 19:1295\u20131301","journal-title":"Mod Path"},{"key":"653_CR14","first-page":"310","volume":"16","author":"A Sessa","year":"2003","unstructured":"Sessa A, Meroni M, Battini G et al (2003) Renal involvement in Anderson\u2013Fabry disease. J Nephrol 16:310\u2013313","journal-title":"J Nephrol"},{"key":"653_CR15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/j.ajkd.2003.09.022","volume":"43","author":"SM Meehan","year":"2004","unstructured":"Meehan SM, Junsanto T, Rydel JJ, Desnick RJ (2004) Fabry disease: renal involvement limited to podocyte pathology and proteinuria in a septuagenarian cardiac variant. Pathologic and therapeutic implications. Am J Kidney Dis 43:164\u2013171","journal-title":"Am J Kidney Dis"},{"key":"653_CR16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00041552-200503000-00002","volume":"14","author":"DG Warnock","year":"2005","unstructured":"Warnock DG (2005) Fabry disease: diagnosis and management, with emphasis on the renal manifestations. Curr Opin Nephrol Hypertens 14:87\u201395","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"653_CR17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1651-2227.2003.tb00212.x","volume":"443","author":"A Sessa","year":"2003","unstructured":"Sessa A, Meroni M, Battini G et al (2003) Evolution of renal pathology in Fabry disease. Acta Paediatr Suppl 443:6\u20138","journal-title":"Acta Paediatr Suppl"},{"key":"653_CR18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000101958","volume":"27","author":"BF Palmer","year":"2007","unstructured":"Palmer BF (2007) Proteinuria as a therapeutic target in patients with chronic kidney disease. Am J Nephrol 27:287\u2013293","journal-title":"Am J Nephrol"},{"key":"653_CR19","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.0954-6820.1947.tb06596.x","volume":"128","author":"AWM Pompen","year":"1947","unstructured":"Pompen AWM, Ruiter M, Wyers HJG (1947) Angiokeratoma corporis diffusum (universale) Fabry, as a sign of an unknown internal disease; two autopsy reports. Acta Med Scand 128:234\u2013255","journal-title":"Acta Med Scand"},{"key":"653_CR20","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1136\/bmj.1.5082.1266","volume":"1","author":"JR Colley","year":"1958","unstructured":"Colley JR, Miller DL, Hutt MSR et al (1958) The renal lesion in angiokeratoma corporis diffusum. Brit M J 1:1266\u20131268","journal-title":"Brit M J"},{"key":"653_CR21","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1056\/NEJM196106222642503","volume":"264","author":"JE Bethune","year":"1961","unstructured":"Bethune JE, Landrigan PL, Chipman CD (1961) Angiokeratoma corporis diffusum universale (Fabry\u2019s disease) in two brothers. New Engl J Med 264:1280\u20131285","journal-title":"New Engl J Med"},{"key":"653_CR22","first-page":"206","volume":"89","author":"EW Henry","year":"1963","unstructured":"Henry EW, Rally CR (1963) The renal lesion in angiokeratoma corporis diffusum (Fabry\u2019s disease). Can Med Assoc J 89:206\u2013213","journal-title":"Can Med Assoc J"},{"key":"653_CR23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000254765","volume":"128","author":"WP Groot","year":"1964","unstructured":"Groot WP (1964) Angiokeratoma corporis diffusum Fabry (Thesaurismosis hereditaria Ruiter\u2013Pompen\u2013Wyers). Dermatologica 128:321\u2013349","journal-title":"Dermatologica"},{"key":"653_CR24","first-page":"361","volume":"1","author":"MW Hartley","year":"1964","unstructured":"Hartley MW, Miller RE, Dempsey HJ, Carroll JF (1964) Dysphospholipidosis in Fabry\u2019s disease: a light and electron microscopic study. Ala J Med Sci 1:361\u2013367","journal-title":"Ala J Med Sci"},{"key":"653_CR25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-9343(67)90027-7","volume":"42","author":"CD Burda","year":"1967","unstructured":"Burda CD, Winder PR (1967) Angiokeratoma corporis diffusum universale (Fabry\u2019s disease) in female subjects. Am J Med 42:293\u2013301","journal-title":"Am J Med"},{"key":"653_CR26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","volume":"81","author":"MH Branton","year":"2002","unstructured":"Branton MH, Schiffmann R, Sabnis SG et al (2002) Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine (Baltimore) 81:122\u2013138","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl A","key":"653_CR27","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S0149-2918(07)80121-4","volume":"29","author":"JP Oliveira","year":"2007","unstructured":"Oliveira JP (2007) Staging of Fabry disease using renal biopsies. Clin Ther 29(Suppl A):S15\u2013S16","journal-title":"Clin Ther"},{"key":"653_CR28","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR et al (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42:1206\u20131252","journal-title":"Hypertension"},{"key":"653_CR29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31\u201341","journal-title":"Nephron"},{"key":"653_CR30","doi-asserted-by":"crossref","first-page":"929","DOI":"10.7326\/0003-4819-141-12-200412210-00009","volume":"141","author":"AD Rule","year":"2004","unstructured":"Rule AD, Larson TS, Bergstralh EJ et al (2004) Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 141:929\u2013937","journal-title":"Ann Intern Med"},{"key":"653_CR31","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1093\/ndt\/17.11.1909","volume":"17","author":"G Vervoort","year":"2002","unstructured":"Vervoort G, Willems HL, Wetzels JFM (2002) Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation. Nephrol Dial Transplant 17:1909\u20131913","journal-title":"Nephrol Dial Transplant"},{"key":"653_CR32","first-page":"225","volume":"54","author":"EA Gehan","year":"1970","unstructured":"Gehan EA, George SL (1970) Estimation of human body surface area from height and weight. Cancer Chemother Rep 54:225\u2013235","journal-title":"Cancer Chemother Rep"},{"issue":"Suppl.1","key":"653_CR33","first-page":"S1","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation (2002) K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39(Suppl.1):S1\u2013S266","journal-title":"Am J Kidney Dis"},{"key":"653_CR34","first-page":"157","volume":"81","author":"RJ Desnick","year":"1973","unstructured":"Desnick RJ, Allen KY, Desnick SJ et al (1973) Fabry\u2019s disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes. J Lab Clin Med 81:157\u2013171","journal-title":"J Lab Clin Med"},{"key":"653_CR35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/ki.1990.208","volume":"38","author":"DA Wiseman","year":"1990","unstructured":"Wiseman DA, Hawkins R, Numerow LM, Taub KJ (1990) Percutaneous renal biopsy utilizing real time, ultrasonic guidance and a semiautomated biopsy device. Kidney Int 38:347\u2013349","journal-title":"Kidney Int"},{"key":"653_CR36","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00041552-200411000-00013","volume":"13","author":"WL Whittier","year":"2004","unstructured":"Whittier WL, Korbet SM (2004) Renal biopsy: update. Curr Opin Nephrol Hypertens 13:661\u2013665","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"653_CR37","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/jcp.53.6.433","volume":"53","author":"PN Furness","year":"2000","unstructured":"Furness PN (2000) ACP best practice No 160: renal biopsy specimens. J Clin Pathol 53:433\u2013438","journal-title":"J Clin Pathol"},{"key":"653_CR38","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/modpathol.3800239","volume":"17","author":"PD Walker","year":"2004","unstructured":"Walker PD, Cavallo T, Bonsib SM, Ad Hoc Committee on Renal Biopsy Guidelines of the Renal Pathology Society (2004) Practice guidelines for the renal biopsy. Mod Path 17:1555\u20131563","journal-title":"Mod Path"},{"key":"653_CR39","unstructured":"Sternberg SS (ed) (1992) Histology for pathologists. Raven, New York"},{"key":"653_CR40","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1681\/ASN.V10122591","volume":"10","author":"G Remuzzi","year":"1999","unstructured":"Remuzzi G, Griny\u00f2 J, Ruggenenti P et al (1999) Early experience with dual kidney transplantation in adults using expanded donor criteria. J Am Soc Nephrol 10:2591\u20132598","journal-title":"J Am Soc Nephrol"},{"key":"653_CR41","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/hmg\/3.6.1019","volume":"3","author":"C Meaney","year":"1994","unstructured":"Meaney C, Blanch LC, Morris CP (1994) A nonsense mutation (R220X) in the \u03b1-galactosidase A gene detected in a female carrier of Fabry disease. Hum Mol Genet 3:1019\u20131020","journal-title":"Hum Mol Genet"},{"key":"653_CR42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"CM Eng","year":"2001","unstructured":"Eng CM, Guffon N, Wilcox WR et al (2001) Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry\u2019s disease. N Engl J Med 345:9\u201316","journal-title":"N Engl J Med"},{"key":"653_CR43","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","volume":"285","author":"R Schiffmann","year":"2001","unstructured":"Schiffmann R, Kopp JB, Austin HA 3rd et al (2001) Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 285:2743\u20132749","journal-title":"JAMA"},{"key":"653_CR44","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1046\/j.1523-1755.2002.00675.x","volume":"62","author":"BL Thurberg","year":"2002","unstructured":"Thurberg BL, Rennke H, Colvin RB et al (2002) Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int 62:1933\u20131946","journal-title":"Kidney Int"},{"key":"653_CR45","doi-asserted-by":"crossref","first-page":"394","DOI":"10.5414\/CNP63394","volume":"63","author":"E Svarstad","year":"2005","unstructured":"Svarstad E, Bostad L, Kaarb\u00f8e O et al (2005) Focal and segmental glomerular sclerosis (FSGS) in a man and a woman with Fabry\u2019s disease. Clin Nephrol 63:394\u2013401","journal-title":"Clin Nephrol"},{"key":"653_CR46","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.HYP.0000167121.14254.a0","volume":"45","author":"AR Chade","year":"2005","unstructured":"Chade AR, Lerman A, Lerman OL (2005) Kidney in early atherosclerosis. Hypertension 45:1042\u20131049","journal-title":"Hypertension"},{"key":"653_CR47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/01.HYP.38.2.171","volume":"38","author":"ERSP Caetano","year":"2001","unstructured":"Caetano ERSP, Zatz R, Saldanha LB, Praxedes JN (2001) Hypertensive nephrosclerosis as a relevant cause of chronic renal failure. Hypertension 38:171\u2013176","journal-title":"Hypertension"},{"key":"653_CR48","first-page":"187","volume-title":"Heptinstall\u2019s pathology of the kidney","author":"JL Olson","year":"1998","unstructured":"Olson JL, Schwartz MM (1998) The nephrotic syndrome: minimal change disease, focal segmental glomerulosclerosis, and miscellaneous causes. In: Jennette JC, Olson JL, Schwartz MM, Silva FG (eds) Heptinstall\u2019s pathology of the kidney, 5th edn. Lippincott-Raven, Philadelphia, pp 187\u2013257","edition":"5"},{"key":"653_CR49","first-page":"85","volume-title":"Renal pathology with clinical and functional correlations","author":"CL Pirani","year":"1994","unstructured":"Pirani CL (1994) Evaluation of kidney biopsy specimens. In: Tisher CG, Brenner BM (eds) Renal pathology with clinical and functional correlations, 2nd edn. Lippincott, Philadelphia, pp 85\u2013115","edition":"2"},{"key":"653_CR50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/01913120590951202","volume":"29","author":"A Tosoni","year":"2005","unstructured":"Tosoni A, Nebuloni M, Zerbi P et al (2005) Ultrastructural study of renal involvement in two females with Anderson\u2013Fabry disease. Ultrastruct Pathol 29:203\u2013207","journal-title":"Ultrastruct Pathol"},{"key":"653_CR51","first-page":"247","volume":"103","author":"T Faraggiana","year":"1981","unstructured":"Faraggiana T, Churg J, Grishman E et al (1981) Light- and electron-microscopic histochemistry of Fabry\u2019s disease. Am J Pathol 103:247\u2013262","journal-title":"Am J Pathol"},{"key":"653_CR52","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1046\/j.1523-1755.1998.00044.x","volume":"54","author":"W Kriz","year":"1998","unstructured":"Kriz W, Gretz N, Lemley KV (1998) Progression of glomerular diseases: is the podocyte the culprit? Kidney Int 54:687\u2013697","journal-title":"Kidney Int"},{"key":"653_CR53","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00041552-199907000-00014","volume":"8","author":"W Kriz","year":"1999","unstructured":"Kriz W, Lemley KV (1999) The role of the podocyte in glomerulosclerosis. Curr Opin Nephrol Hypertens 8:489\u2013497","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"653_CR54","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1097\/01.ASN.0000039661.06947.FD","volume":"13","author":"P Mundel","year":"2002","unstructured":"Mundel P, Shankland SJ (2002) Podocyte biology and response to injury. J Am Soc Nephrol 13:3005\u20133015","journal-title":"J Am Soc Nephrol"},{"key":"653_CR55","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.mnh.0000165884.85803.e1","volume":"14","author":"I Ichikawa","year":"2005","unstructured":"Ichikawa I, Ma J, Motojima M, Matsusaka T (2005) Podocyte damage damages podocytes: autonomous vicious cycle that drives local spread of glomerular sclerosis. Curr Opin Nephrol Hypertens 14:205\u2013210","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"653_CR56","first-page":"71","volume":"47","author":"O Kawamura","year":"1997","unstructured":"Kawamura O, Sakuraba H, Itoh K et al (1997) Subclinical Fabry\u2019s disease occurring in the context of IgA nephropathy. Clin Nephrol 47:71\u201375","journal-title":"Clin Nephrol"},{"key":"653_CR57","first-page":"1303","volume":"36","author":"A Yoshida","year":"1994","unstructured":"Yoshida A, Morozumi K, Takeda A et al (1994) Fabry-like laminated myelin body associated with IgA nephropathy. Nippon Jinzo Gakkai Shi 36:1303\u20131307","journal-title":"Nippon Jinzo Gakkai Shi"},{"key":"653_CR58","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00467-006-0176-5","volume":"21","author":"C Whybra","year":"2006","unstructured":"Whybra C, Schwarting A, Kriegsmann J et al (2006) IgA nephropathy in two adolescent sisters heterozygous for Fabry disease. Pediatr Nephrol 21:1251\u20131256","journal-title":"Pediatr Nephrol"},{"key":"653_CR59","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/sj.ki.5000208","volume":"69","author":"F Breunig","year":"2006","unstructured":"Breunig F, Weidemann F, Strotmann J et al (2006) Clinical benefit of enzyme replacement therapy in Fabry disease. Kidney Int 69:1216\u20131221","journal-title":"Kidney Int"},{"key":"653_CR60","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/ndt\/4.11.943","volume":"4","author":"R Waldherr","year":"1989","unstructured":"Waldherr R, Rambausek M, Duncker WD, Ritz E (1989) Frequency of mesangial IgA deposits in a non-selected autopsy series. Nephrol Dial Transplant 4:943\u2013946","journal-title":"Nephrol Dial Transplant"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-008-0653-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-008-0653-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-008-0653-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T20:24:01Z","timestamp":1738355041000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-008-0653-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,4]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["653"],"URL":"https:\/\/doi.org\/10.1007\/s00428-008-0653-2","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,4]]}}}